Keywords: ALCL, anaplastic large-cell lymphoma; BIA-ALCL, breast implant–associated anaplastic large-cell lymphoma; PC-ALCL, primary cutaneous anaplastic large-cell lymphoma; TMX, trimethoprim/sulfamethoxazole; bacterial antigen; cutaneous T-cell lymphoma; infection; lymphoma; oncology; tumor.